Thermo Fisher Q4 Revenues Climb 6 Percent; Mum on Life Tech Speculation | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that revenues in the fourth quarter improved 6 percent year over year as its Specialty Diagnostics segment saw 12 percent growth.

Revenues for the quarter ended Dec. 31, 2012 totaled $3.26 billion, up from $3.09 billion a year ago, topping the consensus Wall Street estimate of $3.14 billion. Organically, revenues were up 4 percent year over year, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.